Back

New therapeutic strategy targeting regulation of the SERCA2 complex protects from myocardial ischemia-reperfusion injury

28 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Ischaemia reperfusion Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mrs Ana Calejo

Serca Pharmaceuticals, Oslo (Norway)

7 More presentations in this session

Presentation thumbnail
Platelet-derived microRNAs play a pivotal role in cardiac remodeling after myocardial ischemia and reperfusion
Mr J. Schuette (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Mitochondrial succinate transport as a novel therapeutic target for cardiac ischemia/reperfusion injury
Doctor H. Prag (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Discovery and in vivo evaluation of novel inhibitors of the hydrolytic activity of mitochondrial F1Fo ATP synthase to alleviate myocardial ischemia reperfusion injury
Doctor P. Nikolaou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Conditional knock out of cytosolic thioredoxin (Trx) in cardiomyocytes impairs cardiac function and exacerbates ischemia-reperfusion injury
Professor K. Das (Lubbock, US)
Abstract Slides Video
Presentation thumbnail
Temporal proteomic and phosphoproteomic profiling of the left ventricle in a novel rat model of ischemia/reperfusion with or without ischemic preconditioning
Doctor S. Hussain (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Ischaemia reperfusion

The Event

Event poster

ESC Congress 2023

28 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Discovery and in vivo evaluation of novel inhibitors of the hydrolytic activity of mitochondrial F1Fo ATP synthase to alleviate myocardial ischemia reperfusion injury
thumbnail
Congress Presentation
Novel first-in-class drug candidate protects from ischemia-reperfusion injury by targeting the SERCA2 complex
thumbnail
Congress Presentation
Cardiomyocyte-specific beta3-adrenergic receptor expression reduces infarct size inhibiting the autophagic flux in mice.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources